Inactive Instrument

Medicus Sciences Acquisition Corp. Stock Nasdaq

Equities

MSAC.U

KYG5960S1167

Investment Holding Companies

Dynamic Chart
Medicus Sciences Acquisition Corp.(NasdaqCM:MSAC) dropped from NASDAQ Composite Index CI
Medicus Sciences Acquisition to Dissolve, Liquidate MT
Medicus Sciences Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Medicus Sciences Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Medicus Sciences Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Medicus Sciences Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Medicus Sciences Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Medicus Sciences Acquisition Corp. Announces Resignation of Eric Cheng as Chief Business Officer CI
Medicus Sciences Acquisition Corp. cancelled the acquisition of Anteris Technologies Ltd. CI
Medicus Sciences Acquisition Corp. signed a non-binding letter of intent to acquire Anteris Technologies Ltd. CI
Certain Class B Ordinary Shares of Medicus Sciences Acquisition Corp. are subject to a Lock-Up Agreement Ending on 16-AUG-2021. CI
Medicus Sciences Acquisition Corp.(NasdaqCM:MSAC) added to NASDAQ Composite Index CI
Medicus Sciences Acquisition Corp. Announces Board Appointments CI
Medicus Sciences Acquisition Corp. announced that it has received $4.52 million in funding from Medicus Sciences Holdings LLC, Maxim Group, LLC CI
Medicus Sciences Acquisition Corp. has completed an IPO in the amount of $80 million. CI
More news
Managers TitleAgeSince
Chief Executive Officer 54 20-11-25
Director of Finance/CFO 48 20-11-25
Corporate Officer/Principal 54 22-03-24
Members of the board TitleAgeSince
Director/Board Member 53 21-02-11
Chairman 53 20-11-25
Chief Executive Officer 54 20-11-25
More insiders
Medicus Sciences Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target and it has not initiated any substantive discussions, directly or indirectly, with any business combination target. The Company is focused on pursuing an initial business combination opportunity in any industry or geographical location. It intends to focus on the medical technology sector. The Company neither engages in any operations nor generates any revenues.
More about the company